are indistinguishable on Northern blots, but their RT-PCR products can be distinguished by a SalI restriction site specific to rpl-7a. We used this restriction site to cbp-1 mRNA is unchanged in smg(−) mutants, but the quantity of cbp-2ps mRNA is increased approximately distinguish RT-PCR products derived from rpl-7a and rpl-7aps (Figure 3) . rpl-7aps is alternatively spliced in a 6-fold ( Figures 2C and 2D) .
rpl-7aps is a pseudogene derived from rpl-7a, which manner similar to rpl-7a, but unlike rpl-7a, both of its mRNA products are degraded by NMD (Figure 3 ). encodes ribosomal protein L7a. The nucleotide coding sequence of rpl-7aps is 97% identical to that of rpl-7a, Although rpl-7aps is nonfunctional with respect to expression of RPL-7A protein, it likely retains another but it is interrupted by a PTC at codon position 132 of 266. We demonstrated previously that rpl-7a is reguof its ancestral functions. We demonstrated previously that the second intron of rpl-7a is processed to prolated by alternative splicing and expresses both "productively" and "unproductively" spliced mRNAs Pseudogenes may be transcribed long after they have lost function. Expressed pseudogenes will be constrained to avoid the production of disruptive proteins. Once a pseudogene acquires a PTC, however, it will be targeted by mRNA surveillance, reducing its expression and relaxing these constraints. Accumulated mutations will eventually lead to promoter inactivation and sequence degeneration, but may occasionally give rise to new functional proteins or protein domains. 
